Market Place
Sourcing Support
Duality Bio Appoints Hua Mu as Global Chief Medical Officer
07 Apr 2025 //
PR NEWSWIRE
China`s Duality Biotherapeutics tests market with $200M Hong Kong
07 Apr 2025 //
REUTERS
Duality Biologics Achieves Milestone with BeiGene License Exercise
30 Dec 2024 //
PR NEWSWIRE
Duality Expands Adcendo ApS Collaboration via Strategic License
25 Nov 2024 //
PR NEWSWIRE
Duality Plans Hong Kong IPO To Fund BioNTech-Partnered ADC Trials
27 Aug 2024 //
FIERCE BIOTECH
BioNTech, DualityBio steer ADC into PhIII with Enhertu
01 Sep 2023 //
#N/A
DualityBio Expands Global Strategic Partnership with BioNTech for Solid Tumors
07 Aug 2023 //
PR NEWSWIRE
BeiGene bags option on DualityBio ADC in backloaded $1.3B deal
11 Jul 2023 //
FIERCE BIOTECH
BioNTech and DualityBio Form Partnership for ADC Therapeutics for Solid Tumors
04 Apr 2023 //
PRESS RELEASE
Adcendo Announces Agreement with Duality Biologics on ADC Platform
05 Jan 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.